XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2022
Aug. 20, 2019
Jun. 30, 2022
Mar. 31, 2022
Feb. 28, 2022
Jun. 30, 2021
Feb. 28, 2021
Mar. 31, 2021
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Sale Of Stock [Line Items]                              
Common stock, shares authorized 100,000,000   100,000,000           100,000,000       100,000,000   100,000,000
Common stock, par value $ 0.001   $ 0.001           $ 0.001       $ 0.001   $ 0.001
Preferred stock, shares authorized 5,000,000   5,000,000           5,000,000       5,000,000   5,000,000
Preferred stock, par value $ 0.001   $ 0.001           $ 0.001       $ 0.001   $ 0.001
Common stock, shares outstanding 53,710,300   53,710,300           53,710,300       53,710,300   53,480,812
Common stock, shares issued 53,710,300   53,710,300           53,710,300       53,710,300   53,480,812
Preferred stock, shares issued 0   0           0       0   0
Preferred Stock Shares Outstanding 0   0           0       0   0
Non-Exclusive License Agreement | Enteris Biopharma, Inc. [Member]                              
Sale Of Stock [Line Items]                              
Upfront fee payment, cash   $ 4,000                          
Upfront fee payment, stock   $ 4,000                          
Maximum [Member]                              
Sale Of Stock [Line Items]                              
Aggregate offering price of securities       $ 300,000           $ 300,000          
Unsold Securities Under Shelf Registration Statement dated April 4, 2019 [Member]                              
Sale Of Stock [Line Items]                              
Aggregate offering price of securities       154,525           154,525          
Open Market Sales Agreement [Member] | Jeffries LLC [Member]                              
Sale Of Stock [Line Items]                              
Aggregate offering price of securities       $ 80,000           $ 80,000          
Stock Sale Commission Percentage       3.00%                      
Common Stock                              
Sale Of Stock [Line Items]                              
Restricted stock units vested shares                 89,075 109,943 36,000 109,419      
Restricted Stock Units [Member] | General and Administrative [Member]                              
Sale Of Stock [Line Items]                              
Compensation expense                 $ 517   $ 206   $ 1,969 $ 1,027  
Restricted Stock Units [Member] | General and Administrative [Member] | Director [Member]                              
Sale Of Stock [Line Items]                              
Compensation expense                 $ 238   $ 142   $ 377 $ 281  
Restricted Stock Units [Member] | Common Stock | Board of Directors Chairman [Member] | June 2022 [Member]                              
Sale Of Stock [Line Items]                              
Restricted stock units vested shares     11,876                        
Restricted Stock Units [Member] | Common Stock | Director [Member] | June 2022 [Member]                              
Sale Of Stock [Line Items]                              
Vesting period of awards granted     1 year                        
Restricted stock units, vested     43,200                        
Restricted Stock Units [Member] | Common Stock | Director [Member] | June 2021 [Member]                              
Sale Of Stock [Line Items]                              
Vesting period of awards granted           1 year                  
Restricted stock units vested shares           36,000                  
Restricted Stock Units [Member] | Common Stock | Former Chief Executive Officer [Member] | June 2022 [Member]                              
Sale Of Stock [Line Items]                              
Restricted stock units vested shares 33,999                            
Performance Restricted Stock Units [Member] | Common Stock | Executive Officers [Member] | March 2022 [Member]                              
Sale Of Stock [Line Items]                              
Vesting period of awards granted       3 years                      
Restricted stock units, vested       37,999                      
Performance Restricted Stock Units [Member] | Common Stock | Executive Officers [Member] | February and March 2021 [Member]                              
Sale Of Stock [Line Items]                              
Restricted stock units vested shares               76,750              
Time-based Restricted Stock Units [Member] | Common Stock | Executive Officers [Member] | March 2022 [Member]                              
Sale Of Stock [Line Items]                              
Restricted stock units vested shares       39,278                      
Time-based Restricted Stock Units [Member] | Common Stock | Executive Officers [Member] | February 2022 [Member]                              
Sale Of Stock [Line Items]                              
Vesting period of awards granted         3 years                    
Restricted stock units vested shares         32,666                    
Time-based Restricted Stock Units [Member] | Common Stock | Executive Officers [Member] | February 2021 [Member]                              
Sale Of Stock [Line Items]                              
Vesting period of awards granted             3 years                
Restricted stock units vested shares             32,669